Article
Clinical outcomes and molecular typing of heterogenous vancomycin-intermediate Staphylococcus aureus bacteremia in patients in intensive care units.
BMC infectious diseases - 23 Oct 2015
Hu Han-Chung, Kao Kuo-Chin, Chiu Li-Chung, Chang Chih-Hao, Hung Chen-Yiu, Li Li-Fu, Liu Tsui-Ping, Lin Lee-Chung, Chen Ning-Hung, Huang Chung-Chi, Yang Cheng-Ta, Lu Jang-Jih
Abstract excerpt
BACKGROUND: Staphylococcus aureus is one of most common pathogens in humans. Methicillin-resistant S. aureus (MRSA) accounts for 64 % of S. aureus bacteremia isolated in intensive care units (ICUs), and heteroresistant vancomycin-intermediates S. aureus (hVISA) is a phenotype of MRSA. However, studies focusing on the hVISA impact on critically ill patients are scarce. METHODS: This was a retrospective study...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.